Psoriasis in the elderly

Aerlyn G. Dawn, Marianne Edwards Dawn, Gil Yosipovitch

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Psoriasis is one of the most common chronic skin diseases, and unprecedented increases in the elderly population will make diagnosis and management of geriatric psoriasis increasingly important. Management of psoriasis in the elderly requires consideration of several important factors. Many commonly prescribed drugs can precipitate psoriasis or aggravate pre-existing psoriasis. In addition, elderly patients are at increased risk of adverse drug reactions due to polypharmacy, adverse drug-drug interactions, adverse drug-disease interactions, incorrect use of medication and concomitant comorbidities. Psoriasis is a highly variable disease that requires individualized treatment. The major classes of topical medications include topical corticosteroids, coal tar preparations, calcipotriol, tazarotene and salicylic acid. Phototherapy, including narrowband ultraviolet B, photochemotherapy, psoralen ultraviolet A and excimer laser treatment, can be effective in properly selected patients. Systemic therapy for psoriasis in the elderly should be reserved for severe, extensive cases that have failed to respond to topical treatment, and may include methotrexate, systemic retinoids and immunotherapy.

Original languageEnglish (US)
Pages (from-to)611-623
Number of pages13
JournalAging Health
Volume3
Issue number5
DOIs
StatePublished - Oct 1 2007
Externally publishedYes

Fingerprint

Psoriasis
Drug Interactions
Coal Tar
Ficusin
Polypharmacy
Excimer Lasers
Phototherapy
Salicylic Acid
Retinoids
Photochemotherapy
Therapeutics
Drug-Related Side Effects and Adverse Reactions
Skin Diseases
Methotrexate
Geriatrics
Pharmaceutical Preparations
Immunotherapy
Comorbidity
Adrenal Cortex Hormones
Chronic Disease

Keywords

  • Calcipotriol
  • Carticosteroids
  • Coal tar
  • Compliance
  • Drug-induced psoriasis
  • Elderly
  • Immunotherapy
  • Methotrexate
  • Phototherapy
  • Psoriasis
  • Topical

ASJC Scopus subject areas

  • Medicine(all)
  • Geriatrics and Gerontology

Cite this

Psoriasis in the elderly. / Dawn, Aerlyn G.; Dawn, Marianne Edwards; Yosipovitch, Gil.

In: Aging Health, Vol. 3, No. 5, 01.10.2007, p. 611-623.

Research output: Contribution to journalReview article

Dawn, Aerlyn G. ; Dawn, Marianne Edwards ; Yosipovitch, Gil. / Psoriasis in the elderly. In: Aging Health. 2007 ; Vol. 3, No. 5. pp. 611-623.
@article{bf421beb83ff43a0a90a7d515b1fccab,
title = "Psoriasis in the elderly",
abstract = "Psoriasis is one of the most common chronic skin diseases, and unprecedented increases in the elderly population will make diagnosis and management of geriatric psoriasis increasingly important. Management of psoriasis in the elderly requires consideration of several important factors. Many commonly prescribed drugs can precipitate psoriasis or aggravate pre-existing psoriasis. In addition, elderly patients are at increased risk of adverse drug reactions due to polypharmacy, adverse drug-drug interactions, adverse drug-disease interactions, incorrect use of medication and concomitant comorbidities. Psoriasis is a highly variable disease that requires individualized treatment. The major classes of topical medications include topical corticosteroids, coal tar preparations, calcipotriol, tazarotene and salicylic acid. Phototherapy, including narrowband ultraviolet B, photochemotherapy, psoralen ultraviolet A and excimer laser treatment, can be effective in properly selected patients. Systemic therapy for psoriasis in the elderly should be reserved for severe, extensive cases that have failed to respond to topical treatment, and may include methotrexate, systemic retinoids and immunotherapy.",
keywords = "Calcipotriol, Carticosteroids, Coal tar, Compliance, Drug-induced psoriasis, Elderly, Immunotherapy, Methotrexate, Phototherapy, Psoriasis, Topical",
author = "Dawn, {Aerlyn G.} and Dawn, {Marianne Edwards} and Gil Yosipovitch",
year = "2007",
month = "10",
day = "1",
doi = "10.2217/1745509X.3.5.611",
language = "English (US)",
volume = "3",
pages = "611--623",
journal = "Aging Health",
issn = "1745-509X",
publisher = "Future Medicine Ltd.",
number = "5",

}

TY - JOUR

T1 - Psoriasis in the elderly

AU - Dawn, Aerlyn G.

AU - Dawn, Marianne Edwards

AU - Yosipovitch, Gil

PY - 2007/10/1

Y1 - 2007/10/1

N2 - Psoriasis is one of the most common chronic skin diseases, and unprecedented increases in the elderly population will make diagnosis and management of geriatric psoriasis increasingly important. Management of psoriasis in the elderly requires consideration of several important factors. Many commonly prescribed drugs can precipitate psoriasis or aggravate pre-existing psoriasis. In addition, elderly patients are at increased risk of adverse drug reactions due to polypharmacy, adverse drug-drug interactions, adverse drug-disease interactions, incorrect use of medication and concomitant comorbidities. Psoriasis is a highly variable disease that requires individualized treatment. The major classes of topical medications include topical corticosteroids, coal tar preparations, calcipotriol, tazarotene and salicylic acid. Phototherapy, including narrowband ultraviolet B, photochemotherapy, psoralen ultraviolet A and excimer laser treatment, can be effective in properly selected patients. Systemic therapy for psoriasis in the elderly should be reserved for severe, extensive cases that have failed to respond to topical treatment, and may include methotrexate, systemic retinoids and immunotherapy.

AB - Psoriasis is one of the most common chronic skin diseases, and unprecedented increases in the elderly population will make diagnosis and management of geriatric psoriasis increasingly important. Management of psoriasis in the elderly requires consideration of several important factors. Many commonly prescribed drugs can precipitate psoriasis or aggravate pre-existing psoriasis. In addition, elderly patients are at increased risk of adverse drug reactions due to polypharmacy, adverse drug-drug interactions, adverse drug-disease interactions, incorrect use of medication and concomitant comorbidities. Psoriasis is a highly variable disease that requires individualized treatment. The major classes of topical medications include topical corticosteroids, coal tar preparations, calcipotriol, tazarotene and salicylic acid. Phototherapy, including narrowband ultraviolet B, photochemotherapy, psoralen ultraviolet A and excimer laser treatment, can be effective in properly selected patients. Systemic therapy for psoriasis in the elderly should be reserved for severe, extensive cases that have failed to respond to topical treatment, and may include methotrexate, systemic retinoids and immunotherapy.

KW - Calcipotriol

KW - Carticosteroids

KW - Coal tar

KW - Compliance

KW - Drug-induced psoriasis

KW - Elderly

KW - Immunotherapy

KW - Methotrexate

KW - Phototherapy

KW - Psoriasis

KW - Topical

UR - http://www.scopus.com/inward/record.url?scp=35848935182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35848935182&partnerID=8YFLogxK

U2 - 10.2217/1745509X.3.5.611

DO - 10.2217/1745509X.3.5.611

M3 - Review article

AN - SCOPUS:35848935182

VL - 3

SP - 611

EP - 623

JO - Aging Health

JF - Aging Health

SN - 1745-509X

IS - 5

ER -